Recent share price weakness is due to temporary headwinds, including client cost-cutting and delays in biotech decision-making, not structural issues in the CRO industry. Long-term prospects remain ...

While a majority of companies embrace digitization, spreadsheets remain prevalent in R&D teams due to their flexibility and familiarity. However, this flexibility leads to unstructured data, making it ...

In life sciences research and development (R&D), to truly enhance fragmented data, it must be both accessible and relevant. LabVantage BioTech360 serves as the platform that guarantees valuable ...